X0306 4 2020-11-16 1 0001623613 Mylan II B.V. MYL 0001280753 BRESCH HEATHER M BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL UNITED KINGDOM 1 1 0 0 Chief Executive Officer Ordinary Shares 2020-11-16 4 D 0 580642 D 0 D Ordinary Shares 2020-11-16 4 D 0 1157 D 0 I By 401(k) Plan Employee Stock Option - Right to Buy 22.66 2020-11-16 4 D 0 4413 D 2021-03-02 Ordinary Shares 4413 0 D Employee Stock Option - Right to Buy 23.44 2020-11-16 4 D 0 4266 D 2022-02-22 Ordinary Shares 4266 0 D Employee Stock Option - Right to Buy 30.90 2020-11-16 4 D 0 3236 D 2023-03-06 Ordinary Shares 3236 0 D Employee Stock Option - Right to Buy 55.84 2020-11-16 4 D 0 65502 D 2024-03-05 Ordinary Shares 65502 0 D Employee Stock Option - Right to Buy 50.66 2020-11-16 4 D 0 67659 D 2025-11-17 Ordinary Shares 67659 0 D Employee Stock Option - Right to Buy 46.27 2020-11-16 4 D 0 86957 D 2026-02-17 Ordinary Shares 86957 0 D Employee Stock Option - Right to Buy 45.18 2020-11-16 4 D 0 106558 D 2027-03-03 Ordinary Shares 106558 0 D Employee Stock Option - Right to Buy 40.97 2020-11-16 4 D 0 108592 D 2028-03-02 Ordinary Shares 108592 0 D Restricted Stock Units 0.00 2020-11-16 4 D 0 22212 D Ordinary Shares 22212 0 D Performance Restricted Stock Units 0.00 2020-11-16 4 A 0 111057 0.00 A Ordinary Shares 111057 111057 D Performance Restricted Stock Units 0.00 2020-11-16 4 D 0 111057 D Ordinary Shares 111057 0 D Employee Stock Option - Right to Buy 27.45 2020-11-16 4 D 0 91384 D 2029-03-01 Ordinary Shares 91384 0 D Restricted Stock Units 0.00 2020-11-16 4 D 0 102004 D Ordinary Shares 102004 0 D Performance Restricted Stock Units 0.00 2020-11-16 4 A 0 191257 0.00 A Ordinary Shares 191257 191257 D Performance Restricted Stock Units 0.00 2020-11-16 4 D 0 191257 D Ordinary Shares 191257 0 D On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). 300,000 ordinary shares were returned to the reporting person's direct beneficial ownership on September 4, 2020 in the form of a scheduled annuity payment under the terms of the grantor retained annuity trust to which the reporting person initially contributed 300,000 ordinary shares on September 12, 2019. Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. Represents stock options to acquire Mylan ordinary shares ("Mylan Options") that were exchanged for stock options to acquire Viatris common stock ("Viatris Options") having substantially the same terms in connection with the Combination. These options vested on March 2, 2014. These options vested on February 22, 2015. These options vested on March 6, 2016. These options vested on March 5, 2017. These options vested on March 4, 2018. These options vested on February 17, 2019. These options vested on March 3, 2020. Represents Mylan Options that were exchanged for Viatris Options having substantially the same terms in connection with the Combination. The Viatris Options will vest in connection with the reporting person's termination of employment on November 16, 2020 as previously disclosed and consistent with the terms of the original Mylan Options. 36,198 of these options vested on March 2, 2019, 36,197 vested on March 2, 2020 and 36,197 will vest on March 2, 2021. Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. The Viatris RSUs will vest in connection with the reporting person's termination of employment on November 16, 2020 as previously disclosed and consistent with the terms of the original Mylan RSUs. Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021. Each performance restricted stock unit ("PRSU") represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2018, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination. The Viatris RSUs will vest in connection with the reporting person's termination of employment on November 16, 2020 as previously disclosed and consistent with the terms of the original Mylan PRSUs. 30,462 of these options vested on March 2, 2020, and 30,461 will vest on each of March 2, 2021 and March 2, 2022. Each RSU represents the right to receive one ordinary share of Mylan. 51,002 of the RSUs will vest on each of March 2, 2021 and March 2, 2022. Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 1, 2019, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. /s/ Kevin Macikowski, by power of attorney 2020-11-18